1417694-08-6

Basic information

• Product Name: N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride
• CAS NO: 1417694-08-6
• Molecular Weight: 615.172
• Mol File: 1417694-08-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride(1417694-08-6)
• EPA Substance Registry System: N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride(1417694-08-6)

Safety Data

• Hazardous Substances Data: 1417694-08-6(Hazardous Substances Data)

Upstream product

• 1533518-92-1 (R)-2-butoxycarbonylamino-3-(4-ethoxyphenyl)propionic acid 
• 1417694-04-2 (R)-2-amino-3-(4-ethoxyphenyl)propionic acid hydrochloride 
• 108468-00-4 tert-butyl 4-(aminomethyl)benzylcarbamate 
• 3397-32-8 N-(benzyloxycarbonyl)-phenylalanine-N-hydroxysuccinimide ester 
• 76757-92-1 (R)-2-((tert-butoxycarbonyl)amino)-3-(4-ethoxyphenyl)propanoic acid 
• 1417694-06-4 [(R)-1-{(S)-1-[4-(tert-butoxycarbonylaminomethyl)benzylcarbamoyl]-2-phenyl-ethylcarbamoyl}-2-(4-ethoxyphenyl)ethyl]carbamic acid benzyl ester 
• 1417694-05-3 [(R)-1-{(S)-1-[4-(tert-butoxycarbonylamino-methyl)-benzylcarbamoyl]-2-phenyl-ethylcarbamoyl}-2-(4-ethoxy-phenyl)-ethyl]-carbamic acid benzyl ester 
• 561041-07-4 (R)-2-benzyloxycarbonylamino-3-(4-ethoxy-phenyl)-propionic acid 
• 127419-60-7 (R)-2-amino-3-(4-ethoxy-phenyl)-propionic acid 
• 1417694-03-1 {4-[((S)-2-amino-3-phenyl-propionylamino)-methyl]-benzyl}-carbamic acid tert-butyl ester 
• 1417694-02-0 (S)-(1-((4-(((tert-butoxycarbonyl)amino)methyl)benzyl)amino)-1-oxo-3-phenylpropyl-2-yl)carbamic acid benzyl ester 

Relevant articles and documents

POLYMORPHS OF|N-[(R)-1 -[(S)-1-(4-AMINOMETHYL-BENZYLCARBAMOYL)-2-PHENYL-ETHYLCARBAMOY L]-2-(4-E|THOXY-PHENYL)-ETHYL]-BENZAMIDE HYDROCHLORIDE

The invention provides new polymorphs of N-[(R)-l-[(S)-l-(4-aminomethyl- benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride, pharmaceutical compositions containing them and their use in therapy.